Literature DB >> 3207265

Terminal complement complexes (SC5b-9) in cerebrospinal fluid in autoimmune nervous system diseases.

M E Sanders1, E L Alexander, C L Koski, M L Shin, Y Sano, M M Frank, K A Joiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3207265     DOI： 10.1111/j.1749-6632.1988.tb27109.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

Review 1.  B-cells and humoral immunity in multiple sclerosis. Implications for therapy.

Authors:  Sangjin Oh; Cornelia Cudrici; Takahiro Ito; Horea Rus
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 2.  Membrane signaling by complement C5b-9, the membrane attack complex.

Authors:  A Nicholson-Weller; J A Halperin
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 3.  Membrane attack by complement: the assembly and biology of terminal complement complexes.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Snehal Patel; Richard Trippe; Violeta Rus; Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

Review 4.  The complement system in central nervous system diseases.

Authors:  H Rus; F Niculescu
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

5.  Soluble membrane attack complex is diagnostic for intraventricular shunt infection in children.

Authors:  Theresa N Ramos; Anastasia A Arynchyna; Tessa E Blackburn; Scott R Barnum; James M Johnston
Journal:  JCI Insight       Date:  2016-07-07

6.  Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis.

Authors:  Susanna H Weerth; Horea Rus; Moon L Shin; Cedric S Raine
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 7.  Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Violeta Rus; Takahiro Ito; Sonia Vlaicu; Anil Singh; Horea Rus
Journal:  J Neuroimmunol       Date:  2009-07-04       Impact factor: 3.478

8.  IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis.

Authors:  Mahdia Benkhoucha; Nicolas Molnarfi; Marie-Laure Santiago-Raber; Martin S Weber; Doron Merkler; Mattias Collin; Patrice H Lalive
Journal:  J Neuroinflammation       Date:  2012-09-03       Impact factor: 8.322
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.